Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Long-Term Deferred Tax: 2009-2024

Historic Long-Term Deferred Tax for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $248.4 million.

  • Fresenius Medical Care AG's Long-Term Deferred Tax fell 1972.53% to $245.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $245.3 million, marking a year-over-year decrease of 1972.53%. This contributed to the annual value of $248.4 million for FY2024, which is 1869.29% down from last year.
  • According to the latest figures from FY2024, Fresenius Medical Care AG's Long-Term Deferred Tax is $248.4 million, which was down 1869.29% from $305.5 million recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Long-Term Deferred Tax registered a high of $400.9 million during FY2020, and its lowest value of $248.4 million during FY2024.
  • Its 5-year average for Long-Term Deferred Tax is $329.0 million, with a median of $329.5 million in 2022.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Long-Term Deferred Tax tumbled by 88.43% in 2020, and later plummeted by 1869.29% in 2024.
  • Fresenius Medical Care AG's Long-Term Deferred Tax (Annual) stood at $400.9 million in 2020, then decreased by 10.02% to $360.8 million in 2021, then fell by 8.65% to $329.5 million in 2022, then fell by 7.29% to $305.5 million in 2023, then decreased by 18.69% to $248.4 million in 2024.
  • Its last three reported values are $248.4 million in FY2024, $305.5 million for FY2023, and $329.5 million during FY2022.